Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
Saleh Hadi Alharbi
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Na Wang, Chun Zhang
Antioxidants (2024) Vol. 13, Iss. 4, pp. 455-455
Open Access | Times Cited: 43
Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
William Yang Wang, QuangQiu Wang, Xin Qi, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 19
Mechanisms of GLP-1 receptor agonist-induced weight loss: A review of central and peripheral pathways in appetite and energy regulation
Areesha Moiz, Kristian B. Filion, Michael A. Tsoukas, et al.
The American Journal of Medicine (2025)
Open Access | Times Cited: 3
Enhancing Tetrahydrocannabinol’s Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011
Dinesh Thapa, Mohan Patil, Leon N. Warne, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 148-148
Open Access | Times Cited: 2
Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
Rafael Tamayo‐Trujillo, Viviana A. Ruiz‐Pozo, Santiago Cadena-Ullauri, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 14
Real-World Evidence Assessment of the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide
David C. Klonoff, Gavin Hui, Saurabh Gombar
Journal of Diabetes Science and Technology (2024) Vol. 18, Iss. 6, pp. 1517-1518
Closed Access | Times Cited: 11
Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review
Silvano Dragonieri, Andrea Portacci, Vitaliano Nicola Quaranta, et al.
Diseases (2024) Vol. 12, Iss. 9, pp. 224-224
Open Access | Times Cited: 9
Dose-dependent pancreatitis risk associated with GLP-1 agonists
Joyce H Gu, Mark Samarneh
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access | Times Cited: 1
Impact of GLP‐1 Receptor Agonists on Alcohol‐Related Liver Disease Development and Progression in Alcohol Use Disorder
Chia‐Chih Kuo, Chun‐Hsien Li, Min‐Hsiang Chuang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
The potential role of GLP‐1 receptor agonists in osteoarthritis
M P Ryan, Saige Megyeri, Wesley Nuffer, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2025)
Closed Access | Times Cited: 1
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2025) Vol. 187, pp. 171380-171380
Open Access | Times Cited: 1
Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review
Sebastian Badulescu, Aniqa Tabassum, Gia Han Le, et al.
Physiology & Behavior (2024) Vol. 283, pp. 114622-114622
Open Access | Times Cited: 8
Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets
Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 209-209
Open Access | Times Cited: 8
Evolving Strategies for Use of Phytochemicals in Prevention and Long-Term Management of Cardiovascular Diseases (CVD)
D. Haines, Fred M. Cowan, Árpád Tósaki
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6176-6176
Open Access | Times Cited: 5
The Therapeutic Potential of GLP-1 Receptor Agonists in the Management of Hidradenitis Suppurativa: A Systematic Review of Anti-Inflammatory and Metabolic Effects
Piotr Krajewski, Aleksandra Złotowska, Jacek C. Szepietowski
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6292-6292
Open Access | Times Cited: 5
GLP-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data
Lindsey Wang, QuanQiu Wang, Li Li, et al.
JNCI Journal of the National Cancer Institute (2024)
Closed Access | Times Cited: 4
Anorexigenic and anti-inflammatory signaling pathways of semaglutide via the microbiota–gut––brain axis in obese mice
Rodrigo Soares da Silva, Igor Henrique Rodrigues de Paiva, Ingrid Prata Mendonça, et al.
Inflammopharmacology (2024)
Closed Access | Times Cited: 4
The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation
Alberto Sola‐Leyva, Amruta D. S. Pathare, Apostol Apostolov, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2024) Vol. 104, Iss. 2, pp. 258-266
Open Access | Times Cited: 4
Refractory Dysmenorrhea Managed With a Glucagon-Like Peptide-1 Agonist: A Case Report
Mary Helen Tran, Nancy G. Swartz, Sabine D Elisèe
Cureus (2025)
Open Access
Association of GLP1R locus with mental ill‐health endophenotypes and cardiometabolic traits: A trans‐ancestry study in UK Biobank
Madeleine M. E. Hayman, Waneisha Jones, Alisha Aman, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Sodium-Glucose Co-Transporter 2 Inhibitors and Severe Urinary Tract Infections: Real-World Meta-Analysis of Cohort Studies
Mohammed Aboukaoud, Yocheved Morhi, Ester Osher
Annals of Pharmacotherapy (2025)
Closed Access
A 2-Years Comparative Analysis of Tirzepatide, Semaglutide, Qsymia, Contrave, and Phentermine on Ocular Health in Individuals with Obesity: A Propensity-Score Matched Cohort Study
Pen‐Hua Su, Yu‐Nan Huang, Jo-Ching Chen, et al.
Research Square (Research Square) (2025)
Closed Access
Efficacy of three modern anti-diabetic drugs on survival outcomes of lung cancer patients with type 2 diabetes in China
Z. Jeffrey Chen, Ziyi Sun, Zongtao Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Beyond weight loss: exploring the neurological ramifications of altered gut microbiota post-bariatric surgery
Rashed T. Almheiri, Baraa Hajjar, Saif M. I. Alkhaaldi, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Fabry Disease: Insights into Pathophysiology and Novel Therapeutic Strategies
S. Thompson, Ashwin Roy, Tarekegn Geberhiwot, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 624-624
Open Access
Page 1 - Next Page

Scroll to top